Interventionalists don’t often order a CXR ahead of time, but when it’s already been done, some find the added info useful.
A steady stream of structural trial data, approvals, reimbursement decisions, and real-world rollouts arrived in 2025.
The year saw the emergence of a new version of an old drug that proved beneficial in patients who have heart failure with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback